{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:57:45Z","timestamp":1790459865181,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-026-01870-6","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:55:16Z","timestamp":1790344516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Green chiral HPLC method on a polysaccharide column under hydro-organic conditions for the determination of Levobupivacaine, Ropivacaine, and their enantiomeric impurities"],"prefix":"10.1186","volume":"20","author":[{"given":"Nehal G.","family":"Sedki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla N.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha A.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"1870_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/chir.20397","volume":"19","author":"I Ali","year":"2007","unstructured":"Ali I, Gupta VK, Aboul-Enein HY, Singh P, Sharma B. Role of racemization in optically active drugs development. Chirality. 2007;19:453\u201363.","journal-title":"Chirality"},{"key":"1870_CR2","first-page":"1850","volume-title":"The complete drug reference","author":"SC Sweetman","year":"2021","unstructured":"Sweetman SC, Martindale C. The complete drug reference. 37th ed. Pharmaceutical Press; 2021. p. 1850\u201371.","edition":"37"},{"key":"1870_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0889-8537(02)00032-9","volume":"21","author":"M Panni","year":"2003","unstructured":"Panni M, Segal S. New local anesthetics: are they worth the cost? Anesthesiol Clin North America. 2003;21:19\u201338.","journal-title":"Anesthesiol Clin North America"},{"issue":"2","key":"1870_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/0300060513496737","volume":"42","author":"D Gulec","year":"2014","unstructured":"Gulec D, Karsli B, Ertugrul F, Bigat Z, Kayacan N. Intrathecal bupivacaine or levobupivacaine: which should be used for elderly patients? J Int Med Res. 2014;42(2):376\u201385.","journal-title":"J Int Med Res"},{"issue":"4","key":"1870_CR5","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1021\/acs.jmedchem.3c02239","volume":"67","author":"RU Mcvicker","year":"2024","unstructured":"Mcvicker RU. Chirality of new drug approvals (2013\u20132022): trends and perspectives. J Med Chem. 2024;67(4):2305\u201320.","journal-title":"J Med Chem"},{"issue":"2","key":"1870_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.chroma.2008.02.070","volume":"1188","author":"FG S\u00e1nchez","year":"2008","unstructured":"S\u00e1nchez FG, D\u00edaz AN, de Vicente ABM. Enantiomeric resolution of bupivacaine by high-performance liquid chromatography and chiroptical detection. J Chromatogr A. 2008;1188(2):314\u20137.","journal-title":"J Chromatogr A"},{"issue":"44","key":"1870_CR7","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1016\/j.chroma.2009.05.081","volume":"1216","author":"KSS Dossou","year":"2009","unstructured":"Dossou KSS, Chiap P, Chankvetadze B, Servais AC, Fillet M, Crommen J. Enantioresolution of basic pharmaceuticals using cellulose tris(4-chloro-3-methylphenylcarbamate) as chiral stationary phase and polar organic mobile phases. J Chromatogr A. 2009;1216(44):7450\u20135.","journal-title":"J Chromatogr A"},{"issue":"4","key":"1870_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jpba.2010.10.020","volume":"54","author":"KSS Dossou","year":"2011","unstructured":"Dossou KSS, Chiap P, Servais AC, Fillet M, Crommen J. Development and validation of a LC method for the enantiomeric purity determination of S-ropivacaine in a pharmaceutical formulation using a recently commercialized cellulose-based chiral stationary phase and polar non-aqueous mobile phase. J Pharm Biomed Anal. 2011;54(4):687\u201393.","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"1870_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1080\/00032719708004046","volume":"30","author":"M Siluveru","year":"1997","unstructured":"Siluveru M, Stewart JT. Enantiomeric HPLC separations of chiral local anesthetics using cellulose based chiral stationary phases. Anal Lett. 1997;30(6):1167\u201378.","journal-title":"Anal Lett"},{"issue":"7","key":"1870_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.2174\/0115734110321087240918112556","volume":"21","author":"AH Shaik","year":"2025","unstructured":"Shaik AH, Kotanka RR, Ruthala KK, Gandholi SR, Nalla K. Novel chiral HPLC method for accurate identification and quantification of RS enantiomers in ropivacaine on immobilized chiral stationary phase: development and validation. Curr Anal Chem. 2025;21(7):816\u201328.","journal-title":"Curr Anal Chem"},{"issue":"11\/12","key":"1870_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/BF02492491","volume":"54","author":"C Rustichelli","year":"2001","unstructured":"Rustichelli C, Ferioli V, Gamberini G, Stancanelli R. Enantiomeric separation of local anaesthetic drug by HPLC on chiral stationary phases 1). Chromatographia. 2001;54(11\/12):731\u20136.","journal-title":"Chromatographia"},{"key":"1870_CR12","volume-title":"Ropivacaine Hydrochloride injection","author":"United States Pharmacopeial Convention","year":"2026","unstructured":"United States Pharmacopeial Convention. Ropivacaine Hydrochloride injection. Rockville: United States Pharmacopeial Convention (USP\/NF); 2026."},{"key":"1870_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0021-9673(95)01195-1","volume":"737","author":"A Amini","year":"1996","unstructured":"Amini A, Beijersten I, Pettersson C, Westerlund D. Enantiomeric separation of local anesthetic drugs by micellar electrokinetic capillary chromatography with taurodeoxycholate as chiral selector. J Chromatogr A. 1996;737:301\u201313.","journal-title":"J Chromatogr A"},{"issue":"1","key":"1870_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.31083\/ph.2012.1050","volume":"67","author":"YY Li","year":"2012","unstructured":"Li YY, Yu Y, Zhu P, Duan G, Li YY, Song F. Chiral separation of bupivacaine hydrochloride by capillary electrophoresis with high frequency conductivity detection and its application to rabbit serum and pharmaceutical injection. Pharmazie. 2012;67(1):25\u201330.","journal-title":"Pharmazie"},{"issue":"2","key":"1870_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/(SICI)1096-9888(199802)33:2<183::AID-JMS622>3.0.CO;2-V","volume":"33","author":"EM J\u00e4verfalk","year":"1998","unstructured":"J\u00e4verfalk EM, Amini A, Westerlund D, Andr\u00e9n PE. Chiral separation of local anaesthetics by a capillary electrophoresis\/partial filling technique coupled on-line to micro- electrospray mass spectrometry. J Mass Spectrom. 1998;33(2):183\u20136.","journal-title":"J Mass Spectrom"},{"issue":"3\u20134","key":"1870_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0731-7085(01)00577-5","volume":"27","author":"S Cherkaoui","year":"2002","unstructured":"Cherkaoui S, Veuthey JL. Use of negatively charged cyclodextrins for the simultaneous enantioseparation of selected anesthetic drugs by capillary electrophoresis-mass spectrometry. J Pharm Biomed Anal. 2002;27(3\u20134):615\u201326.","journal-title":"J Pharm Biomed Anal"},{"issue":"5\/6","key":"1870_CR17","first-page":"263","volume":"42","author":"JJ Martinez-Pla","year":"1996","unstructured":"Martinez-Pla JJ, Martin-Biosca Y, Sagrado S, Villanueva-Camanas RM, Medina-Hernandez MJJ. Chiral separation of bupivacaine hydrochloride by capillary electrophoresis with high-frequency conductivity detection and its application to rabbit serum and pharmaceutical injection. Pharmazie. 1996;42(5\/6):263\u20138.","journal-title":"Pharmazie"},{"key":"1870_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0928-0987(99)00035-4","volume":"9","author":"A Amini","year":"1999","unstructured":"Amini A, Wiersma B, Westerlund D, Paulsen-Sorman U. Determination of the enantiomeric purity of S-ropivacaine by capillary electrophoresis with methyl-b-cyclodextrin as chiral selector using conventional and complete filling techniques. Eur J Pharm Sci. 1999;9:17\u201324.","journal-title":"Eur J Pharm Sci"},{"key":"1870_CR19","volume-title":"Ropivacaine Hydrochloride","author":"United States Pharmacopeial Convention","year":"2026","unstructured":"United States Pharmacopeial Convention. Ropivacaine Hydrochloride. Rockville: United States Pharmacopeial Convention (USP\/NF); 2026."},{"key":"1870_CR20","unstructured":"European Directorate for the Quality of Medicines & HealthCare. Ropivacaine Hydrochloride. In: European Pharmacopeia, 11th edn. Strasbourg: Council of Europe; 2025."},{"issue":"2","key":"1870_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.5155\/eurjchem.5.2.214-218.964","volume":"5","author":"NNED Salama","year":"2014","unstructured":"Salama NNED. Rapid chiral separation and impurity determination of ropivacaine and bupivacaine by Densitometry-HPTLC, using mucopolysaccharide as chiral mobile phase additive. Eur J Chem. 2014;5(2):214\u20138.","journal-title":"Eur J Chem"},{"issue":"1\u20132","key":"1870_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.chroma.2005.10.003","volume":"1101","author":"R Cirilli","year":"2006","unstructured":"Cirilli R, Simonelli A, Ferretti R, Bolasco A, Chimenti P, Secci D, et al. Analytical and semipreparative high performance liquid chromatography enantioseparation of new substituted 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H) -pyrazoles on polysaccharide-based chiral stationary phases in normal-phase, polar organic and reversed-. J Chromatogr A. 2006;1101(1\u20132):198\u2013203.","journal-title":"J Chromatogr A"},{"issue":"2","key":"1870_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0021-9673(00)00862-1","volume":"902","author":"T Wang","year":"2000","unstructured":"Wang T, Chen YW, Vailaya A. Enantiomeric separation of some pharmaceutical intermediates and reversal of elution orders by high-performance liquid chromatography using cellulose and amylose tris(3,5-dimethylphenylcarbamate) derivatives as stationary phases. J Chromatogr A. 2000;902(2):345\u201355.","journal-title":"J Chromatogr A"},{"issue":"1","key":"1870_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chroma.2007.11.027","volume":"1177","author":"R Cirilli","year":"2008","unstructured":"Cirilli R, Ferretti R, Gallinella B, De Santis E, Zanitti L, La Torre F. High-performance liquid chromatography enantioseparation of proton pump inhibitors using the immobilized amylose-based Chiralpak IA chiral stationary phase in normal-phase, polar organic and reversed-phase conditions. J Chromatogr A. 2008;1177(1):105\u201313.","journal-title":"J Chromatogr A"},{"key":"1870_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/chir.22525","volume":"27","author":"S Rizzo","year":"2015","unstructured":"Rizzo S, Menta S, Benincori T, Ferretti R, Pierini M, Cirilli R, et al. Determination of the enantiomerization barrier of the residual enantiomers of C 3-symmetric tris[3-(1-methyl-2-alkyl)indolyl] phosphane oxides: case study of a multitasking HPLC investigation based on an immobilized polysaccharide stationary phase. Chirality. 2015;27:888\u201399.","journal-title":"Chirality"},{"key":"1870_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.chroma.2013.11.020","volume":"1324","author":"F Ortuso","year":"2014","unstructured":"Ortuso F, Alcaro S, Menta S, Fioravanti R, Cirilli R. A chromatographic and computational study on the driving force operating in the exceptionally large enantioseparation of N-thiocarbamoyl-3-(4\u2019-biphenyl)-5-phenyl-4,5-dihydro-(1H) pyrazole on a 4-methylbenzoate cellulose-based chiral stationary phase. J Chromatogr A. 2014;1324:71\u20137.","journal-title":"J Chromatogr A"},{"issue":"28","key":"1870_CR27","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1016\/j.chroma.2009.05.034","volume":"1216","author":"R Ferretti","year":"2009","unstructured":"Ferretti R, Gallinella B, La Torre F, Zanitti L, Turchetto L, Mosca A, et al. Direct high-performance liquid chromatography enantioseparation of terazosin on an immobilised polysaccharide-based chiral stationary phase under polar organic and reversed-phase conditions. J Chromatogr A. 2009;1216(28):5385\u201390.","journal-title":"J Chromatogr A"},{"key":"1870_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.chroma.2012.07.070","volume":"1269","author":"AA Younes","year":"2012","unstructured":"Younes AA, Mangelings D, Vander HY. Chiral separations in reversed-phase liquid chromatography: evaluation of several polysaccharide-based chiral stationary phases for a separation strategy update. J Chromatogr A. 2012;1269:154\u201367.","journal-title":"J Chromatogr A"},{"key":"1870_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chroma.2019.460445","volume":"1609","author":"Z Shedania","year":"2020","unstructured":"Shedania Z, Kakava R, Volonterio A, Farkas T, Chankvetadze B. Separation of enantiomers of chiral sulfoxides in high-performance liquid chromatography with cellulose-based chiral selectors using acetonitrile and acetonitrile-water mixtures as mobile phases. J Chromatogr A. 2020;1609:1\u201311.","journal-title":"J Chromatogr A"},{"issue":"7","key":"1870_CR30","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.chroma.2009.11.040","volume":"1217","author":"T Zhang","year":"2010","unstructured":"Zhang T, Nguyen D, Franco P. Reversed-phase screening strategies for liquid chromatography on polysaccharide-derived chiral stationary phases. J Chromatogr A. 2010;1217(7):1048\u201355.","journal-title":"J Chromatogr A"},{"key":"1870_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-4939-9438-0_7","volume-title":"Chiral separations : methods in molecular biology","author":"R Cirilli","year":"2019","unstructured":"Cirilli R. Enantioseparations with polysaccharide-based chiral stationary phases in HILIC conditions. In: Scriba GKE, editor. Chiral separations\u202f: methods in molecular biology. New York: Humana; 2019. p. 127\u201346."},{"key":"1870_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.chroma.2014.02.071","volume":"1339","author":"B Gallinella","year":"2014","unstructured":"Gallinella B, Bucciarelli L, Zanitti L, Ferretti R, Cirilli R. Direct separation of the enantiomers of oxaliplatin on a cellulose-based chiral stationary phase in hydrophilic interaction liquid chromatography mode ( R, R ). J Chromatogr A. 2014;1339:210\u20133.","journal-title":"J Chromatogr A"},{"key":"1870_CR33","first-page":"1","volume":"222","author":"SRK Murthy","year":"2023","unstructured":"Murthy SRK, Venkatanarayana M, Narayana L, Sekhara BC, Vemparala M, Fareed A, et al. Chiral LC method development: Stereo-selective separation, characterization, and determination of cabotegravir and related RS, RR, and SS isomeric impurities on coated cellulose-based chiral stationary phase by HILIC-LC and LC-MS. J Pharm Biomed Anal. 2023;222:1\u201313.","journal-title":"J Pharm Biomed Anal"},{"key":"1870_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0021-9673(00)96972-3","volume":"499","author":"AJ Alpert","year":"1990","unstructured":"Alpert AJ. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J Chromatogr A. 1990;499:177\u201396.","journal-title":"J Chromatogr A"},{"key":"1870_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.chroma.2017.06.026","volume":"1523","author":"DV McCalley","year":"2017","unstructured":"McCalley DV. Understanding and manipulating the separation in hydrophilic interaction liquid chromatography. J Chromatogr A. 2017;1523:49\u201371.","journal-title":"J Chromatogr A"},{"key":"1870_CR36","unstructured":"Consumer medicine information: Chirocaine; Solution For injection concentrated solution for infusion [Internet]. 2016 [cited 2022 Mar 11]. https:\/\/www.nps.org.au\/assets\/medicines\/0273b1d3-3723-44e9-8886-a53300ff01ff-reduced.pdf"},{"key":"1870_CR37","unstructured":"Product monograph naropin \u00ae [Internet]. 2018 [cited 2022 Mar 11]. https:\/\/pdf.hres.ca\/dpd_pm\/00045953.PDF"},{"key":"1870_CR38","unstructured":"Guideline on validation of analytical procedures. ICH Q2(R2). International conference on harmonization; 2024."},{"key":"1870_CR39","unstructured":"Stalcup AM. Chiral separations. In: Annual review of analytical chemistry. 2010. p. 126\u20137."},{"issue":"1\u20132","key":"1870_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0021-9673(94)80401-X","volume":"666","author":"E K\u00fcsters","year":"1994","unstructured":"K\u00fcsters E, Loux V, Schmid E, Floersheim P. Enantiomeric separation of chiral sulphoxides. Screening of cellulose-based sorbents with particular reference to cellulose tribenzoate. J Chromatogr A. 1994;666(1\u20132):421\u201332.","journal-title":"J Chromatogr A."}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-026-01870-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01870-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01870-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:02:32Z","timestamp":1790456552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13065-026-01870-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1870"],"URL":"https:\/\/doi.org\/10.1186\/s13065-026-01870-6","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable since the studies involved in this work didn\u2019t include human participants, human data, or human tissue.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable since the work doesn\u2019t contain any person\u2019s data in any form.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"192"}}